300199.SZ
翰宇药业
SZSE · Healthcare · C 制造业 · CN
CNY 22.17
−4.03%Margins
Gross margin
60.3%
EBITDA margin
21.7%
EBIT margin
13.6%
Net margin
9.9%
FCF margin
-1.5%
12.7%
Return on equity
2.8%
Return on assets
5.1%
Return on invested capital
0.29x
Asset turnover
CNY 263.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026